Your browser doesn't support javascript.
loading
No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.
Wright, Edwina J; Grund, Birgit; Robertson, Kevin R; Cysique, Lucette; Brew, Bruce J; Collins, Gary L; Poehlman-Roediger, Mollie; Vjecha, Michael J; Penalva de Oliveira, Augusto César; Standridge, Barbara; Carey, Cate; Avihingsanon, Anchalee; Florence, Eric; Lundgren, Jens D; Arenas-Pinto, Alejandro; Mueller, Nicolas J; Winston, Alan; Nsubuga, Moses S; Lal, Luxshimi; Price, Richard W.
Afiliação
  • Wright EJ; Department of Infectious Diseases Alfred Health, Monash University, Burnet Institute, The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Grund B; School of Statistics, University of Minnesota, Minneapolis, Minnesota.
  • Robertson KR; Department of Neurology, University of North Carolina, North Carolina, USA.
  • Cysique L; Neurosciences Research Australia, St. Vincent's Hospital Sydney, Applied Medical Research Centre.
  • Brew BJ; Neurosciences Program, Peter Duncan Neurosciences Unit, St Vincent's Centre for Applied Medical Research, University of New South Wales, Sydney, Australia.
  • Collins GL; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
  • Poehlman-Roediger M; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
  • Vjecha MJ; Institute for Clinical Research, Inc, Washington, DC, USA.
  • Penalva de Oliveira AC; Instituto Emilio Ribas, Sao Paulo, Brazil.
  • Standridge B; Veterans Affairs Medical Center, Washington DC, USA.
  • Carey C; Kirby Institute, University of New South Wales, Sydney, Australia.
  • Avihingsanon A; HIV-NAT Thai Red Cross AIDS Research Centre and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Florence E; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
  • Lundgren JD; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Denmark.
  • Arenas-Pinto A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Mueller NJ; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.
  • Winston A; Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.
  • Nsubuga MS; People in Need Agency (PINA), Uganda.
  • Lal L; Burnet Institute, Melbourne, Australia.
  • Price RW; Department of Neurology, University of California San Francisco, San Francisco, California, USA.
AIDS ; 32(8): 985-997, 2018 05 15.
Article em En | MEDLINE | ID: mdl-29424786
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Complexo AIDS Demência / Antirretrovirais / Prevenção Secundária Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Complexo AIDS Demência / Antirretrovirais / Prevenção Secundária Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: AIDS Assunto da revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália